Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-11

Clinical Trial Update: Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing letrozole to observation in newly diagnosed uterine leiomyosarcoma; trial terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leiomyosarcoma, Uterine Neoplasm | Phase 2 | Status: TERMINATED | Results posted: 2018-10-11